Flow Cytometry Market to Witness Steady Growth in the Near Future

The worldwide flow cytometry market size was esteemed at USD 6.3 billion out of 2020 and is relied upon to extend at an accumulated yearly development rate (CAGR) of 8.9% from 2021 to 2027.

Factors like the high predominance of focused illnesses and expanding R interests in biotechnology, clinical, and life science research are required to altogether fuel market development over the gauge time frame.

It is utilized to describe and characterize various sorts of cells in a heterogeneous cell populace and works with surveying the virtue of segregated subpopulations.

Rising R drives by different central participants for the improvement of multicolor tests and progressed reagents for examination are driving the market.

Following the episode, various exploration establishments and pharma organizations are associated with broad R exercises for the improvement of new antibodies and treatments.

This has spurred a colossal interest in flow cytometry answers for research applications.

The major factors driving the growth of the flow cytometry market are the technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities and clinical trials, the growing focus on immunology and immuno-oncology research, high incidence and prevalence of HIV-AIDS and cancer, and availability of novel application-specific flow cytometry products.The global Flow Cytometry Market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, at a CAGR of 8.1%Recent Developments :-In 2018, Becton, Dickinson and Company (US) launched BD FACSymphony S6 High Parameter Cell Sorter.In 2018, Agilent Technologies, Inc. (US) entered into an agreement to acquire ACEA Biosciences Inc. (US) to expand its global revenue base, product portfolio, and strengthen its market share.In 2018, Merck KGaA (Germany) launched the CellStream benchtop flow cytometer system.Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584The growing market penetration in emerging countries, growth in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry technologies are expected to present a wide range of growth opportunities for market players.The flow cytometry market is segmented on the basis of products and services into reagents and consumables, instruments, services, software, and accessories.

The reagents and consumables segment is expected to command the largest share of the global flow cytometry market in 2018.

Factors such as the development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities) are expected to drive the growth of the reagents and consumables market in the coming years.Geographical Analysis:- The market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of APAC), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa.

North America is expected to account for the largest share of the global flow cytometry market in 2018.Read more ( Flow cytometry market ): https://www.marketsandmarkets.com/PressReleases/flow-cytometry.aspMajor Key players :-The major players operating in the flow cytometry market are Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US) and Apogee Flow Systems Ltd. (UK).

About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

The Latin America Flow Cytometry Market is estimated to touch US$ 566.5 million by the completion of the prediction period.

Growing number of sick people, greater unmet necessities, and demand for speedy, precise analytical apparatuses are the important reasons motivating the Latin America flow cytometry market above the prediction period.Growing demand for quicker and precise leukemia predictive apparatuses combined with growing occurrence percentage, is estimated to drive the market in nearby future.

Increasing extensive manufacture of proteins, improvement of cell line, and additional biologicals together with increasing demand for cell categorization and examination methods were responsible for more than 30% stake of the entire market income in during the year 2014.

The subdivision of Instruments retained stake of more than 43.0% of the income during the year 2014 and is projected to develop at a CAGR of more than 11.0% above the prediction period.The Latin America Flow Cytometry on the source of Type of Technology could span Bead based, Cell based.

Moreover, the overview of technically progressive automatic micro capillary cytometry, uniting the capability of bioinformatics and machinelike for examination of cell, is estimated to increase infiltration of the same in the nearby years.

Conversely, the subdivision of “bead-based” is likely to develop at a profitable CAGR of more than 11.0%,over the prediction period.The Latin America Flow Cytometry on the source of Area with respect to Trades in terms of intake, Profits, Market stake, and Development percentage in these areas, for the duration of the prediction could span Uruguay, Argentina, Ecuador, Colombia, Cuba, Panama, Guatemala, Chile, Peru, Venezuela, Brazil, Republic Dominican, Costa Rica, Mexico.By the source of geography, Latin America flow cytometry industry pertains to 14 nations holding enormous upcoming development openings; for example Uruguay, Argentina, Ecuador, Colombia, Cuba, Panama, Guatemala, Chile, Peru, Venezuela, Brazil, Republic Dominican a, Costa Rica, Mexico.

The global Flow Cytometry Market size was estimated at USD 3.27 billion in 2016 and is anticipated to grow at CAGR of 10.6% in coming years.

Key drivers of this market include increasing incidence of chronic disorders that requires toxicity testing for cancer tests and need for quick, accurate and sensitive prognosis techniques for the validation of disease.

Increasing awareness levels amongst healthcare experts and patients coupled with rising healthcare expenditures are major factors driving the growth.

This analysis is applied in the discovery of drug for physiological importance of results.

The development of new innovative technologies including the multi-color flow cytometers combined with the ability to detect up to eighteen cell parameters concurrently is amongst the causes leading towards growth.

The entry of reagents and multiplex probes for definite usage in diagnostics and discovery of drug is anticipated to benefit this vertical accompanied with development opportunities by offering the users in research and small- scale peripheral laboratories.